2-phenoxyacetamidine | 100377-17-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-phenoxyacetamidine
• 英文别名: Phenoxyessigsaeure-amidin；C-Phenoxy-acetamidin；2-Phenoxy-acetamidin；2-phenoxyethanimidamide；Phenoxyacetamidine
• CAS: 100377-17-1
• 化学式: C₈H₁₀N₂O
• 分子量: 150.18
• InChiKey: GGJZNRRFDCKJCD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  59.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-phenoxyacetamidine 在 sodium hydroxide 作用下， 以 乙醇 为溶剂， 生成 2-Phenoxymethyl-4(3H)-pteridinone
  参考文献：
  名称：

  Synthesis and potential antiallergic activity of new pteridinones and related compounds

  摘要：

  The synthesis and pharmacological profile of a series of 2-alkoxy and 2-phenoxymethyl-3H-pteridin-4-ones and related compounds are described. These compounds displayed antiallergic activity in the passive cutaneous anaphylaxis test in rats. In contrast to both sodium cromoglycate and nedocromil sodium, many of our compounds were active when administered orally. The most potent in this series, 2-ethoxymethyl-3H-pteridin-4-one 2b (LCB 2183) was investigated in other models of allergy and inflammation. The antiallergic activity was confirmed and interesting antiinflammatory properties were observed. It was therefore selected for further development as a human therapeutic agent.

  DOI：

  10.1016/0223-5234(96)80364-3

文献信息

• Pot, atom and step economic synthesis: a diversity-oriented approach to construct 2-substituted pyrrolo[2,1-f][1,2,4]triazin-4(3H)-ones
  作者：Haoyue Xiang、Yanhong Chen、Qian He、Yuyuan Xie、Chunhao Yang

  DOI：10.1039/c3ra22909b

  日期：——

  A diversity-oriented approach to construct 2-heteroaryl-substituted pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one derivatives via copper-promoted two-step one pot reactions from chromenone derivatives has been developed. Pot, atom and step economy (PASE) were combined in these sequential reactions, and at least six bonds were formed in one pot. A number of drug-like small molecules were prepared quickly and efficiently.

  一种以多样性为导向的方法，通过铜促进的两步一锅法反应，从色烯酮衍生物构建2-杂芳基取代的吡咯并[2,1-f][1,2,4]三嗪-4(3H)-酮衍生物已被开发。这些序列反应中结合了反应釜、原子及步骤经济性（PASE），并且在一锅中至少形成了六种键。许多类药物的小分子被迅速高效地制备出来。
• 4(3H)-pteridinones, preparation processes and drugs containing them
  申请人：Lipha, Lyonnaise Industrielle Pharmaceutique

  公开号：US05167949A1

  公开（公告）日：1992-12-01

  The present invention relates to 4(3H)-pteridinones represented by the formula: ##STR1## in which X is an oxygen atom or a sulphur atom, Y is a hydrogen atom, a lower alkyl radical, especially a methyl radical, at the 6-position or a hydroxyl group at the 7-position, R.sub.1 is a hydrogen atom, a lower alkyl radical, a substituted or unsubstituted phenyl radical, a benzyl radical, a methoxymethyl group, an acetyl group, a 2-acetoxyethyl group or a 2,2,2-trifluoroethyl group and R.sub.2 is a hydrogen atom or a lower alkyl radical, especially a methyl radical. Application of these compounds as anti-allergic drugs.

  本发明涉及具有以下通式的4(3H)-蝶啶酮：##STR1##其中X是氧原子或硫原子，Y是氢原子、低级烷基基团，特别是6位上的甲基基团或7位上的羟基基团，R1是氢原子、低级烷基基团、取代或未取代的苯基基团、苄基基团、甲氧基甲基基团、乙酰基基团、2-乙酸氧乙基基团或2,2,2-三氟乙基基团，R2是氢原子或低级烷基基团，特别是甲基基团。这些化合物作为抗过敏药物的应用。
• Novel imidazole derivatives, their preparation and their use as medicaments
  申请人：Bigg Dennis

  公开号：US20070066542A1

  公开（公告）日：2007-03-22

  Novel imidazole compounds of the formula wherein the substituents are as defined in the application having antitumoral activity and use thereof.

  具有抗肿瘤活性的新型咪唑化合物，其化学式为其中取代基如申请中所定义。以及其使用方法。
• 4(3H)-pteridinone compounds
  申请人：Lipha, Lyonnaise Industrille Pharmaceutique

  公开号：US05270465A1

  公开（公告）日：1993-12-14

  The present invention relates to 4(3H)-pteridinones represented by the formula: ##STR1## in which X is an oxygen atom or a sulphur atom, Y is a hydrogen atom, a lower alkyl radical, especially a methyl radical, at the 6-position or a hydroxyl group at the 7-position, R.sub.1 is a hydrogen atom, a lower alkyl radical, a substituted or unsubstituted phenyl radical, a benzyl radical, a methoxymethyl group, an acetyl group, a 2-acetoxyethyl group or a 2,2,2-trifluoroethyl group and R.sub.2 is a hydrogen atom or a lower alkyl radical, especially a methyl radical. Application of these compounds as anti-allergic drugs.

  本发明涉及由以下式表示的4（3H）-喹嗪酮：##STR1## 其中，X是氧原子或硫原子，Y是氢原子，低碳基，特别是甲基基团，在6位或7位处是羟基基团，R1是氢原子，低碳基，取代或未取代的苯基基团，苄基基团，甲氧基甲基基团，乙酰基基团，2-乙酰氧乙基基团或2,2,2-三氟乙基基团，R2是氢原子或低碳基，特别是甲基基团。这些化合物的应用作为抗过敏药物。
• CANNABINOID RECEPTOR MEDIATING COMPOUNDS
  申请人：The United States of America, as represented by the Secretary, Department of Health and Human Serv

  公开号：US20160257654A1

  公开（公告）日：2016-09-08

  A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB 1 receptor mediating scaffold and (ii) a second therapeutic scaffold.

  一种化合物，或其药学上可接受的盐或酯，包括（i）CB1受体介导的支架和（ii）第二个治疗支架。